Oncology Market Specialist
Paula Boultbee is nothing short of an impassioned expert in the field of oncology, initially treating and assisting patients as an Oncology RN and later realizing a career as a senior executive leading marketing initiatives for numerous breakthrough cancer treatments – she has dedicated her entire professional life to oncology.
A multi-disciplined specialist, Paula’s extensive skillset spans global commercialization planning, pre-launch preparation, major launch initiatives for first-in-class agents, and patient advocacy.
Her list of notable accomplishments in the biopharma sector includes introducing and supporting brands like Imbruvica (ibrutinib), Glivec/Gleevec (imatinib), Aranesp (darbopoetin), Camptosar (irinotecan), and Vectibix (panitumumab). In addition, she has held top-tier positions, as well as consulted, for major companies including Pharmacia (Pfizer), Novartis, Amgen, Proteolix (Onyx), Dendreon, Incyte, and Pharmacyclics, among others.
Paula’s extensive knowledge of oncology, and hands-on attention to organizational detail has made a demonstrable impact on the success of many top-of-mind brands. As an oncology market specialist working with FreshBlood, Paula is available to organize, strategize and lead a team through the myriad obstacles and opportunities that define today’s complex healthcare marketplace.
Paula serves on the Board of Directors of the Max Foundation – a global health non-profit organization that believes all people living with cancer have the right to access the best treatment and support. By partnering with industry, non-governmental agencies, health care providers, and national cancer patient organizations, Paula’s work through the Max Foundation is helping people in more than 100 countries.